BK
Earnings weren’t the only thing getting upgraded
BNY Mellon came out of its first-quarter 2026 report looking like the kid who aced the test and somehow still got extra credit. Shares barely budged Thursday, but the real action happened in analyst-land, where multiple firms bumped up their price targets after the bank posted better-than-expected results.
The new numbers are doing the heavy lifting
The bank reported diluted EPS of $2.24, up 42% year over year, with adjusted EPS of $2.25 easily topping Wall Street’s $1.93 estimate. Revenue also climbed 13% to a record $5.409 billion, which is the kind of “we’re doing just fine, thanks” print that tends to make analysts reach for their spreadsheets and a brighter shade of optimism.
Wall Street basically said: fair enough
Here’s the mini parade of raised targets:
- Keefe, Bruyette & Woods lifted its target from $143 to $150 and kept an Outperform rating
- Evercore ISI raised its target from $119 to $136 and stayed In Line
- Truist bumped its target from $140 to $148 and kept a Buy
For investors, that matters because analyst revisions often help set the next leg of sentiment after earnings season. If you already liked BK’s clean quarter, this is Wall Street adding a little confetti on top.
Big picture: BNY Mellon isn’t just showing growth — it’s getting a louder thumbs-up from the Street, and that can help keep the stock’s momentum from fading too fast.